{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:51:31Z","timestamp":1793029891165,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is insufficient understanding of the molecular basis of prostate cancer (PCa) across different populations. We perform a large-scale proteome-wide association study\u00a0(PWAS) to identify proteins with genetically regulated expression in plasma to be associated with PCa risk across populations. We develop genetic prediction models for expression of 1578, 1993, 1218, and 1390 proteins for African (n\u2009=\u2009450), European (n\u2009=\u2009758), Asian (n\u2009=\u2009289), and Hispanic\/Latino (n\u2009=\u2009474) males, respectively, and evaluate associations of genetically regulated protein expression with PCa risk in 19,391 PCa cases and 61,608 controls of African population, 122,188 cases and 604,640 controls of European population, 10,809 cases and 95,790 controls of Asian population, and 3931 cases and 26,405 controls of Hispanic\/Latino population. We identify three, four, 15, and 73 PCa-associated proteins in African, Hispanic\/Latino, Asian, and European populations, respectively, and 83 in trans-population meta-analysis. There are both pan-population and population-specific associations. Our findings provide valuable insights into etiology of PCa.<\/jats:p>","DOI":"10.1038\/s41467-025-66250-5","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:33:52Z","timestamp":1765013632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proteome-wide association study of prostate cancer risk across populations"],"prefix":"10.1038","volume":"17","author":[{"given":"Hua","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-1785","authenticated-orcid":false,"given":"Chong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9364-8572","authenticated-orcid":false,"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus P.","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Durda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-5068","authenticated-orcid":false,"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-3753","authenticated-orcid":false,"given":"Craig W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-0486","authenticated-orcid":false,"given":"Henry J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit I.","family":"Yarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-795X","authenticated-orcid":false,"given":"Ani W.","family":"Manichaikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-7793","authenticated-orcid":false,"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-1723","authenticated-orcid":false,"given":"Jerome I.","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-1980","authenticated-orcid":false,"given":"Ruth F.","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-8882","authenticated-orcid":false,"given":"Peter","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-3627","authenticated-orcid":false,"given":"Lang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"66250_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"66250_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00345-011-0801-1","volume":"30","author":"K Hemminki","year":"2012","unstructured":"Hemminki, K. Familial risk and familial survival in prostate cancer. World J. Urol. 30, 143\u2013148 (2012).","journal-title":"World J. Urol."},{"key":"66250_CR3","unstructured":"Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet. 50, 928\u2013936 (2018)."},{"key":"66250_CR4","unstructured":"Wang, A. et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat. Genet. 55, 2065\u20132074 (2023)."},{"key":"66250_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/bib\/bby035","volume":"20","author":"ER Chimusa","year":"2019","unstructured":"Chimusa, E. R., Dalvie, S., Dandara, C., Wonkam, A. & Mazandu, G. K. Post genome-wide association analysis: dissecting computational pathway\/network-based approaches. Brief. Bioinform. 20, 690\u2013700 (2019).","journal-title":"Brief. Bioinform."},{"key":"66250_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ng.840","volume":"43","author":"ML Freedman","year":"2011","unstructured":"Freedman, M. L. et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat. Genet. 43, 513\u2013518 (2011).","journal-title":"Nat. Genet."},{"key":"66250_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ajhg.2013.10.012","volume":"93","author":"SL Edwards","year":"2013","unstructured":"Edwards, S. L., Beesley, J., French, J. D. & Dunning, A. M. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93, 779\u2013797 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"66250_CR8","first-page":"1","volume":"11","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk. Nat. Commun. 11, 1\u201311 (2020).","journal-title":"Nat. Commun."},{"key":"66250_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ijc.33808","volume":"150","author":"D Liu","year":"2022","unstructured":"Liu, D. et al. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. Int J. Cancer 150, 80\u201390 (2022).","journal-title":"Int J. Cancer"},{"key":"66250_CR10","doi-asserted-by":"crossref","unstructured":"Zhong, H., Liu, S., Zhu, J. & Wu, L. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk. Int. J. Cancer 153, 103\u2013110 (2023).","DOI":"10.1002\/ijc.34466"},{"key":"66250_CR11","doi-asserted-by":"crossref","unstructured":"Wu, L. et al. Identification of novel susceptibility loci and genes for prostate cancer risk: a transcriptome-wide association study in over 140,000 European Descendants. Cancer Res. 79, 3192\u20133204 (2019).","DOI":"10.1158\/0008-5472.CAN-18-3536"},{"key":"66250_CR12","doi-asserted-by":"crossref","unstructured":"Stephan, C. et al. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network. Biol. Chem. 387, 801\u2013805 (2006).","DOI":"10.1515\/BC.2006.101"},{"key":"66250_CR13","unstructured":"Nakashima, J. et al. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin. Cancer Res. 6, 2702\u20132706 (2000)."},{"key":"66250_CR14","doi-asserted-by":"crossref","unstructured":"Uetsuki, H. et al. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. J. Urol. 174, 514\u2013518 (2005).","DOI":"10.1097\/01.ju.0000165154.41159.b1"},{"key":"66250_CR15","doi-asserted-by":"crossref","unstructured":"Burgess, S., Small, D. S. & Thompson, S. G. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 26, 2333\u20132355 (2017).","DOI":"10.1177\/0962280215597579"},{"key":"66250_CR16","doi-asserted-by":"crossref","unstructured":"Bal\u00e1zs, K., Antal, L., S\u00e1fr\u00e1ny, G. & Lumniczky, K. Blood-derived biomarkers of diagnosis, prognosis and therapy response in prostate cancer patients. J. Personal. Med. 11, 296 (2021).","DOI":"10.3390\/jpm11040296"},{"key":"66250_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","volume":"54","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 54, 593\u2013602 (2022).","journal-title":"Nat. Genet."},{"key":"66250_CR18","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/hmg\/ddad139","volume":"32","author":"H Zhong","year":"2023","unstructured":"Zhong, H. et al. Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140,000 subjects. Hum. Mol. Genet. 32, 3181\u20133193 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"66250_CR19","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1158\/0008-5472.CAN-18-3997","volume":"79","author":"L Wu","year":"2019","unstructured":"Wu, L. et al. Analysis of Over 140,000 European Descendants identifies genetically predicted blood protein biomarkers associated with prostate cancer risk. Cancer Res. 79, 4592\u20134598 (2019).","journal-title":"Cancer Res."},{"key":"66250_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41568-018-0087-3","volume":"19","author":"S Farashi","year":"2019","unstructured":"Farashi, S., Kryza, T., Clements, J. & Batra, J. Post-GWAS in prostate cancer: from genetic association to biological contribution. Nat. Rev. Cancer 19, 46\u201359 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"66250_CR21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang, G., Zhao, D., Spring, D. J. & DePinho, R. A. Genetics and biology of prostate cancer. Genes Dev. 32, 1105\u20131140 (2018).","journal-title":"Genes Dev."},{"key":"66250_CR22","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"66250_CR23","doi-asserted-by":"crossref","unstructured":"Guo, J. et al. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target. Tissue Cell 72, 101546 (2021).","DOI":"10.1016\/j.tice.2021.101546"},{"key":"66250_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet 53, 65\u201375 (2021).","journal-title":"Nat. Genet"},{"key":"66250_CR25","doi-asserted-by":"crossref","unstructured":"Jiang, J. et al. ANO7 African-ancestral genomic diversity and advanced prostate cancer. Prostate Cancer Prostatic Dis. 27, 558\u2013565 (2024).","DOI":"10.1038\/s41391-023-00722-x"},{"key":"66250_CR26","doi-asserted-by":"crossref","unstructured":"Rayford, W. et al. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun. Biol. 4, 670 (2021).","DOI":"10.1038\/s42003-021-02140-y"},{"key":"66250_CR27","first-page":"1211","volume":"14","author":"D Liu","year":"2021","unstructured":"Liu, D. et al. Associations between genetically predicted plasma N-glycans and prostate cancer risk: analysis of over 140,000 European descendants. Pharmgenom. Pers. Med. 14, 1211 (2021).","journal-title":"Pharmgenom. Pers. Med."},{"key":"66250_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-94252-y","volume":"11","author":"N Brandes","year":"2021","unstructured":"Brandes, N., Linial, N. & Linial, M. Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition. Sci. Rep. 11, 1\u201316 (2021).","journal-title":"Sci. Rep."},{"key":"66250_CR29","doi-asserted-by":"crossref","unstructured":"Turay, D. et al. Proteomic profiling of serum-derived exosomes from ethnically diverse prostate cancer patients. Cancer Investig. 34, 1\u201311 (2016).","DOI":"10.3109\/07357907.2015.1081921"},{"key":"66250_CR30","doi-asserted-by":"crossref","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","DOI":"10.1038\/s41586-018-0175-2"},{"key":"66250_CR31","doi-asserted-by":"crossref","unstructured":"Lilja, H., Ulmert, D. & Vickers, A. J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Revi. Cancer 8, 268\u2013278 (2008).","DOI":"10.1038\/nrc2351"},{"key":"66250_CR32","doi-asserted-by":"crossref","unstructured":"Whitaker, H. C., Warren, A. Y., Eeles, R., Kote-Jarai, Z. & Neal, D. E. The potential value of microseminoprotein-\u03b2 as a prostate cancer biomarker and therapeutic target. Prostate 70, 333\u2013340 (2010).","DOI":"10.1002\/pros.21059"},{"key":"66250_CR33","doi-asserted-by":"crossref","unstructured":"Benatzy, Y., Palmer, M. A. & Br\u00fcne, B. Arachidonate 15-lipoxygenase type B: regulation, function, and its role in pathophysiology. Front. Pharmacol. 13, 1042420 (2022).","DOI":"10.3389\/fphar.2022.1042420"},{"key":"66250_CR34","doi-asserted-by":"crossref","unstructured":"Gregg, J. & Fraizer, G. Transcriptional regulation of EGR1 by EGF and the ERK signaling pathway in prostate cancer cells. Genes Cancer 2, 900\u2212909 (2011).","DOI":"10.1177\/1947601911431885"},{"key":"66250_CR35","doi-asserted-by":"crossref","unstructured":"Mehta, H. H. et al. IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res. 71, 5154\u22125163 (2011).","DOI":"10.1158\/0008-5472.CAN-10-4513"},{"key":"66250_CR36","doi-asserted-by":"crossref","unstructured":"Hockla, A. et al. PRSS3\/mesotrypsin is a therapeutic target for metastatic prostate cancer. Mol. Cancer Res. 10, 1555\u22121566 (2012).","DOI":"10.1158\/1541-7786.MCR-12-0314"},{"key":"66250_CR37","doi-asserted-by":"crossref","unstructured":"Tregunna, R. Serum MMP7 levels could guide metastatic therapy for prostate cancer. Nat. Rev. Urol. 17, 658\u2212658 (2020).","DOI":"10.1038\/s41585-020-00396-3"},{"key":"66250_CR38","doi-asserted-by":"crossref","unstructured":"Pierconti, F. et al. Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate 71, (2011).","DOI":"10.1002\/pros.21245"},{"key":"66250_CR39","doi-asserted-by":"crossref","unstructured":"Kojima, S., Inahara, M., Suzuki, H., Ichikawa, T. & Furuya, Y. Implications of insulin-like growth factor-I for prostate cancer therapies: Review Article. Int. J. Urol. 16, 161\u2013167 (2009).","DOI":"10.1111\/j.1442-2042.2008.02224.x"},{"key":"66250_CR40","doi-asserted-by":"crossref","unstructured":"Wu, J. & Yu, E. Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy. Cancer and Metastasis Reviews 33, 607\u2013617 (2014).","DOI":"10.1007\/s10555-013-9482-0"},{"key":"66250_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.omto.2019.03.012","volume":"14","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma. Mol. Ther. Oncolytics 14, 82\u201393 (2019).","journal-title":"Mol. Ther. Oncolytics"},{"key":"66250_CR42","doi-asserted-by":"crossref","unstructured":"Tagirasa, R. & Yoo, E. Role of Serine Proteases at the Tumor-Stroma Interface. Front. Immunol. 13, 832418 (2022).","DOI":"10.3389\/fimmu.2022.832418"},{"key":"66250_CR43","doi-asserted-by":"crossref","unstructured":"Barton, J., Blackledge, G. & Wakeling, A. Growth factors and their receptors: new targets for prostate cancer therapy. (2001).","DOI":"10.1016\/S0090-4295(01)01253-5"},{"key":"66250_CR44","doi-asserted-by":"crossref","unstructured":"Nguyen, D. P., Li, J. & Tewari, A. K. Inflammation and prostate cancer: The role of interleukin 6 (IL-6). BJU Int. 113, 986\u2013992 (2014).","DOI":"10.1111\/bju.12452"},{"key":"66250_CR45","doi-asserted-by":"crossref","unstructured":"Stewart, D. A., Cooper, C. R. & Sikes, R. A. Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod. Biol. Endocrinol. 2, 2 (2004).","DOI":"10.1186\/1477-7827-2-2"},{"key":"66250_CR46","doi-asserted-by":"crossref","unstructured":"Akaza, H. Future prospects for luteinizing hormone-releasing hormone analogues in prostate cancer treatment. Pharmacology 85, 110\u2013120 (2010).","DOI":"10.1159\/000274486"},{"key":"66250_CR47","doi-asserted-by":"crossref","unstructured":"Huerta-Reyes, M. et al. Treatment of breast cancer with gonadotropin-releasing hormone analogs. Front. Oncol. 9, 943 (2019).","DOI":"10.3389\/fonc.2019.00943"},{"key":"66250_CR48","doi-asserted-by":"publisher","unstructured":"Prostate cancer cells tricked into self-destruction because of their hunger for copper. Pharm J. https:\/\/doi.org\/10.1211\/pj.2014.20066843 (2015).","DOI":"10.1211\/pj.2014.20066843"},{"key":"66250_CR49","unstructured":"Kaushik, A. K. et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat. Commun. 7, 11612 (2016)."},{"key":"66250_CR50","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-020-01429-2","volume":"39","author":"K Shah","year":"2020","unstructured":"Shah, K. et al. Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing. Oncogene 39, 6172\u20136189 (2020).","journal-title":"Oncogene"},{"key":"66250_CR51","doi-asserted-by":"crossref","unstructured":"Penney, K. L. et al. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol. Biomark. Prevent. 24, 255\u2013260 (2015).","DOI":"10.1158\/1055-9965.EPI-14-0694-T"},{"key":"66250_CR52","doi-asserted-by":"crossref","unstructured":"Desai, T. A. et al. Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. EBioMedicine 105, 105168 (2024).","DOI":"10.1016\/j.ebiom.2024.105168"},{"key":"66250_CR53","doi-asserted-by":"crossref","unstructured":"Ren, F., Jin, Q., Liu, T., Ren, X. & Zhan, Y. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers. J. Transl. Med. 21, 646 (2023).","DOI":"10.1186\/s12967-023-04525-5"},{"key":"66250_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-025-00724-x","volume":"19","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development. Hum. Genom. 19, 17 (2025).","journal-title":"Hum. Genom."},{"key":"66250_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.91","volume":"40","author":"G Thomas","year":"2008","unstructured":"Thomas, G. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet 40, 310\u2013315 (2008).","journal-title":"Nat. Genet"},{"key":"66250_CR56","unstructured":"Eeles, R. A. et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316\u2013321 (2008)."},{"key":"66250_CR57","doi-asserted-by":"crossref","unstructured":"Lou, H. et al. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc. Natl. Acad. Sci. USA 106, 7933\u20137938 (2009).","DOI":"10.1073\/pnas.0902104106"},{"key":"66250_CR58","doi-asserted-by":"crossref","unstructured":"Camp, N. J. et al. Replication of the 10q11 and Xp11 prostate cancer risk variants: Results from a Utah pedigree-based study. Cancer Epidemiol. Biomark. Prevent. 18, 1290\u20131294 (2009).","DOI":"10.1158\/1055-9965.EPI-08-0327"},{"key":"66250_CR59","doi-asserted-by":"crossref","unstructured":"Chang, B. L. et al. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum. Mol. Genet. 18, (2009).","DOI":"10.1093\/hmg\/ddp035"},{"key":"66250_CR60","doi-asserted-by":"crossref","unstructured":"Mhatre, D. R. et al. The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects. Springerplus 4, 380 (2015).","DOI":"10.1186\/s40064-015-1164-7"},{"key":"66250_CR61","doi-asserted-by":"crossref","unstructured":"Xu, B. et al. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression. Prostate 70, 1146\u22121152 (2010).","DOI":"10.1002\/pros.21149"},{"key":"66250_CR62","doi-asserted-by":"crossref","unstructured":"Su, J. et al. LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas. Front. Oncol. 9, 1083 (2019).","DOI":"10.3389\/fonc.2019.01083"},{"key":"66250_CR63","doi-asserted-by":"crossref","unstructured":"Chen, L. et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K\/Akt pathway. Cell Death Dis. 11, 320 (2020).","DOI":"10.1038\/s41419-020-2535-8"},{"key":"66250_CR64","doi-asserted-by":"crossref","unstructured":"Zeng, C. et al. DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2. Cancer Med. 12, 412\u2212424 (2023).","DOI":"10.1002\/cam4.4926"},{"key":"66250_CR65","doi-asserted-by":"crossref","unstructured":"Zhang, G. et al. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS ONE 7, e31507 (2012).","DOI":"10.1371\/journal.pone.0031507"},{"key":"66250_CR66","doi-asserted-by":"crossref","unstructured":"Iljin, K. et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin. Cancer Res. 15, 6070\u22126078 (2009).","DOI":"10.1158\/1078-0432.CCR-09-1035"},{"key":"66250_CR67","doi-asserted-by":"crossref","unstructured":"Lin, J. et al. Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate 71, 333\u2212343 (2011).","DOI":"10.1002\/pros.21247"},{"key":"66250_CR68","doi-asserted-by":"crossref","unstructured":"Schweizer, M. T. et al. Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer. Prostate Cancer Prostatic Dis. 16, 357\u2212361 (2013).","DOI":"10.1038\/pcan.2013.28"},{"key":"66250_CR69","doi-asserted-by":"crossref","unstructured":"Zhang, T. et al. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer. Prostate 82, (2022).","DOI":"10.1002\/pros.24329"},{"key":"66250_CR70","doi-asserted-by":"crossref","unstructured":"Lim, J. T. E. et al. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem. Pharmacol. 58, 1097\u22121107 (1999).","DOI":"10.1016\/S0006-2952(99)00200-2"},{"key":"66250_CR71","doi-asserted-by":"crossref","unstructured":"Nortcliffe, A. et al. Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment. Bioorg. Med. Chem. 22, 756\u2212761 (2014).","DOI":"10.1016\/j.bmc.2013.12.014"},{"key":"66250_CR72","unstructured":"Uslu, R. et al. Arsenic trioxide-mediated cytotoxicity and apoptosis inprostate and ovarian carcinoma cell lines. Clin. Cancer Res. 6, 4957\u22124964 (2000)."},{"key":"66250_CR73","unstructured":"Maeda, H. et al. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61, 5432\u22125440 (2001)."},{"key":"66250_CR74","doi-asserted-by":"crossref","unstructured":"Berry, W., Dakhil, S., Gregurich, M. A. & Asmar, L. Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate. Semin Oncol. 28, 8\u201315 (2001).","DOI":"10.1016\/S0093-7754(01)90149-6"},{"key":"66250_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"66250_CR76","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild, D. E. et al. Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156, 871\u2013881 (2002).","journal-title":"Am. J. Epidemiol."},{"key":"66250_CR77","doi-asserted-by":"publisher","first-page":"e1007586","DOI":"10.1371\/journal.pgen.1007586","volume":"14","author":"LS Mogil","year":"2018","unstructured":"Mogil, L. S. et al. Genetic architecture of gene expression traits across diverse populations. PLoS Genet. 14, e1007586 (2018).","journal-title":"PLoS Genet."},{"key":"66250_CR78","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1371\/journal.pgen.0020190","volume":"2","author":"N Patterson","year":"2006","unstructured":"Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, 2074\u20132093 (2006).","journal-title":"PLoS Genet."},{"key":"66250_CR79","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439\u20133440 (2005).","journal-title":"Bioinformatics"},{"key":"66250_CR80","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations. Diabetologia https:\/\/doi.org\/10.1007\/S00125-024-06277-3 (2024).","DOI":"10.1007\/S00125-024-06277-3"},{"key":"66250_CR81","doi-asserted-by":"crossref","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2212252 (2016).","DOI":"10.1038\/ng.3506"},{"key":"66250_CR82","doi-asserted-by":"crossref","unstructured":"Robinson, G. K. That BLUP is a good thing: the estimation of random effects. Stat. Sci. 6, 15\u221232 (1991).","DOI":"10.1214\/ss\/1177011926"},{"key":"66250_CR83","doi-asserted-by":"crossref","unstructured":"Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. Ser. B 58, 267\u2212288 (1996).","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"key":"66250_CR84","doi-asserted-by":"crossref","unstructured":"Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B Stat. Methodol. 67, 301\u2212320 (2005).","DOI":"10.1111\/j.1467-9868.2005.00503.x"},{"key":"66250_CR85","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhong, H., Zhu, J. & Wu, L. Identification of blood metabolites associated with risk of Alzheimer\u2019s disease by integrating genomics and metabolomics data. Mol.Psychiatry 29, 1153\u20131162 (2024).","DOI":"10.1038\/s41380-023-02400-9"},{"key":"66250_CR86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-023-01378-4","volume":"16","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Associations between genetically predicted plasma protein levels and Alzheimer\u2019s disease risk: a study using genetic prediction models. Alzheimers Res. Ther. 16, 8 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"66250_CR87","doi-asserted-by":"crossref","unstructured":"He, J. et al. Enhancing disease risk gene discovery by integrating transcription factor-linked trans-variants into transcriptome-wide association analyses. Nucleic Acids Res. 53, gkae1035 (2025).","DOI":"10.1093\/nar\/gkae1035"},{"key":"66250_CR88","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ng.3367","volume":"47","author":"ER Gamazon","year":"2015","unstructured":"Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091\u20131098 (2015).","journal-title":"Nat. Genet."},{"key":"66250_CR89","doi-asserted-by":"crossref","unstructured":"Zhu, J. et al. Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma. Gigascience 13, giae012 (2024).","DOI":"10.1093\/gigascience\/giae012"},{"key":"66250_CR90","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"},{"key":"66250_CR91","unstructured":"Graff, M. et al. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. Am. J. Hum. Genet. 108, 564\u2212582 (2021)."},{"key":"66250_CR92","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1080\/01621459.2023.2183127","volume":"118","author":"H Xue","year":"2023","unstructured":"Xue, H., Shen, X. & Pan, W. Causal inference in transcriptome-wide association studies with invalid instruments and GWAS summary data. J. Am. Stat. Assoc. 118, 1525\u20131537 (2023).","journal-title":"J. Am. Stat. Assoc."},{"key":"66250_CR93","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","DOI":"10.1126\/science.347.6227.1274-c"},{"key":"66250_CR94","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"66250_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-3-3-291","volume":"3","author":"B Lehne","year":"2009","unstructured":"Lehne, B. & Schlitt, T. Protein-protein interaction databases: keeping up with growing interactomes. Hum. Genom. 3, 1\u20137 (2009).","journal-title":"Hum. Genom."},{"key":"66250_CR96","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. Jr & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"66250_CR97","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668\u2013D672 (2006).","journal-title":"Nucleic Acids Res."},{"key":"66250_CR98","doi-asserted-by":"crossref","unstructured":"Koscielny, G. et al. Open Targets: a platform for therapeutic target identification and Validation. Nucleic Acids Res. 45, D985\u2212D994 (2017).","DOI":"10.1093\/nar\/gkw1055"},{"key":"66250_CR99","doi-asserted-by":"publisher","unstructured":"Hua, Z. Proteome-wide association study of prostate cancer risk across populations. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.17280225 (2025).","DOI":"10.5281\/ZENODO.17280225"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66250-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:20:00Z","timestamp":1774959600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66250-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66250"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66250-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lang Wu provided consulting services to Pupil Bio Inc., Techspert, and Galiher DeRobertis & Waxman LLP, and reviewed manuscripts for\n                      Gastroenterology Report\n                      , not related to this study, and received honorarium. No potential conflicts of interest were disclosed by the other authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3043"}}